1,1-dichloroethene increases expression ISO RGD:62097 6480464 vinylidene chloride results in increased expression of FGF7 mRNA CTD PMID:26682919 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of FGF7 mRNA CTD PMID:30723492 17beta-estradiol increases expression ISO RGD:69203 6480464 Estradiol results in increased expression of FGF7 mRNA, Estradiol results in increased expression of FGF7 protein CTD PMID:14999240 , PMID:21098263 17beta-estradiol increases expression ISO RGD:62097 6480464 Estradiol results in increased expression of FGF7 mRNA CTD PMID:19484750 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:62097 6480464 [2 more ... CTD PMID:25510870 2,2',5,5'-tetrachlorobiphenyl multiple interactions ISO RGD:62097 6480464 [2 more ... CTD PMID:25510870 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:62097 6480464 Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of FGF7 mRNA] CTD PMID:16054899 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:62097 6480464 Tetrachlorodibenzodioxin results in increased expression of FGF7 mRNA CTD PMID:15034205 2-amino-2-deoxy-D-glucopyranose decreases expression EXP 6480464 Glucosamine results in decreased expression of FGF7 mRNA CTD PMID:17109745 2-amino-2-deoxy-D-glucopyranose multiple interactions EXP 6480464 IL1B inhibits the reaction [Glucosamine results in decreased expression of FGF7 mRNA] CTD PMID:17109745 3,3',5-triiodo-L-thyronine decreases expression ISO RGD:69203 6480464 Triiodothyronine results in decreased expression of FGF7 mRNA CTD PMID:15507505 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:62097 6480464 [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of FGF7 mRNA more ... CTD PMID:16054899 3-methylcholanthrene multiple interactions ISO RGD:62097 6480464 [Methylcholanthrene co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of FGF7 mRNA CTD PMID:23519560 5-azacytidine decreases expression ISO RGD:69203 6480464 Azacitidine results in decreased expression of FGF7 mRNA CTD PMID:20823114 5-fluorouracil decreases response to substance ISO RGD:69203 6480464 FGF7 protein results in decreased susceptibility to Fluorouracil, FGF7 results in decreased susceptibility to Fluorouracil CTD PMID:18575591 5-fluorouracil multiple interactions ISO RGD:69203 6480464 FGFR2 inhibits the reaction [FGF7 results in decreased susceptibility to Fluorouracil], FGFR2 protein alternative form inhibits the reaction [FGF7 protein results in decreased susceptibility to Fluorouracil] CTD PMID:18575591 acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of FGF7 mRNA CTD PMID:28959563 aldehydo-D-glucosamine decreases expression EXP 6480464 Glucosamine results in decreased expression of FGF7 mRNA CTD PMID:17109745 aldehydo-D-glucosamine multiple interactions EXP 6480464 IL1B inhibits the reaction [Glucosamine results in decreased expression of FGF7 mRNA] CTD PMID:17109745 aldehydo-D-glucose affects transport ISO RGD:62097 6480464 FGF7 protein affects the transport of Glucose CTD PMID:12757114 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of FGF7 mRNA CTD PMID:16483693 anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions ISO RGD:69203 6480464 pyrazolanthrone inhibits the reaction [FGF7 protein results in increased expression of FAS protein] more ... CTD PMID:15677771 , PMID:16162944 antirheumatic drug increases expression ISO RGD:69203 6480464 Antirheumatic Agents results in increased expression of FGF7 mRNA CTD PMID:24449571 ANTU increases expression EXP 6480464 alpha-naphthyl thiourea results in increased expression of FGF7 mRNA CTD PMID:10755703 arabinoxylan increases expression ISO RGD:69203 6480464 arabinoxylan results in increased expression of FGF7 mRNA CTD PMID:15678371 Aroclor 1254 increases expression ISO RGD:62097 6480464 Chlorodiphenyl (54% Chlorine) results in increased expression of FGF7 mRNA CTD PMID:23650126 arsane decreases expression ISO RGD:62097 6480464 Arsenic results in decreased expression of FGF7 mRNA CTD PMID:19654921 arsenic atom decreases expression ISO RGD:62097 6480464 Arsenic results in decreased expression of FGF7 mRNA CTD PMID:19654921 arsenous acid decreases expression ISO RGD:69203 6480464 Arsenic Trioxide results in decreased expression of FGF7 mRNA CTD PMID:20458559 azathioprine increases expression ISO RGD:69203 6480464 Azathioprine results in increased expression of FGF7 mRNA CTD PMID:19192274 benzo[a]pyrene decreases expression ISO RGD:62097 6480464 Benzo(a)pyrene results in decreased expression of FGF7 mRNA CTD PMID:15034205 beta-D-glucosamine decreases expression EXP 6480464 Glucosamine results in decreased expression of FGF7 mRNA CTD PMID:17109745 beta-D-glucosamine multiple interactions EXP 6480464 IL1B inhibits the reaction [Glucosamine results in decreased expression of FGF7 mRNA] CTD PMID:17109745 bis(2-chloroethyl) sulfide decreases expression ISO RGD:62097 6480464 Mustard Gas results in decreased expression of FGF7 mRNA CTD PMID:15674843 bis(2-chloroethyl) sulfide multiple interactions ISO RGD:69203 6480464 TNF protein affects the reaction [Mustard Gas affects the expression of FGF7 mRNA] CTD PMID:16173061 bisphenol A increases expression ISO RGD:62097 6480464 bisphenol A results in increased expression of FGF7 mRNA CTD PMID:27022677 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of FGF7 mRNA CTD PMID:25181051 boric acid increases expression ISO RGD:69203 6480464 boric acid results in increased expression of FGF7 protein CTD PMID:27206737 cadmium dichloride multiple interactions ISO RGD:69203 6480464 Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of and results in increased secretion of FGF7 protein], Cadmium Chloride results in increased expression of and results in increased secretion of FGF7 protein CTD PMID:26138014 carbon nanotube decreases expression ISO RGD:62097 6480464 Nanotubes, Carbon results in decreased expression of FGF7 mRNA CTD PMID:25554681 cholesterol multiple interactions ISO RGD:69203 6480464 Cholesterol inhibits the reaction [FGF7 protein results in increased expression of FAS mRNA], Cholesterol inhibits the reaction [FGF7 protein results in increased expression of SCD mRNA] CTD PMID:16162944 cholesterol multiple interactions EXP 6480464 [1, 2-dioleoyloxy-3-(trimethylammonium)propane co-treated with Cholesterol] results in increased expression of FGF7 protein CTD PMID:16034455 cisplatin increases expression ISO RGD:62097 6480464 Cisplatin results in increased expression of FGF7 mRNA CTD PMID:21151649 cisplatin multiple interactions ISO RGD:69203 6480464 [Cisplatin co-treated with Paclitaxel] results in increased expression of FGF7 mRNA CTD PMID:20705681 cyclosporin A decreases expression ISO RGD:69203 6480464 Cyclosporine results in decreased expression of FGF7 mRNA, Cyclosporine results in decreased expression of FGF7 protein CTD PMID:15250830 cyclosporin A increases expression ISO RGD:69203 6480464 Cyclosporine results in increased expression of FGF7 mRNA, Cyclosporine results in increased expression of FGF7 protein CTD PMID:15250830 D-glucose affects transport ISO RGD:62097 6480464 FGF7 protein affects the transport of Glucose CTD PMID:12757114 dermatan sulfate increases activity ISO RGD:62097 6480464 Dermatan Sulfate analog results in increased activity of FGF7 protein CTD PMID:15563459 dexamethasone multiple interactions ISO RGD:62097 6480464 [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of FGF7 mRNA more ... CTD PMID:16054899 diarsenic trioxide decreases expression ISO RGD:69203 6480464 Arsenic Trioxide results in decreased expression of FGF7 mRNA CTD PMID:20458559 doxorubicin decreases expression EXP 6480464 Doxorubicin results in decreased expression of FGF7 mRNA CTD PMID:12632370 fluoranthene multiple interactions ISO RGD:62097 6480464 [1-methylanthracene co-treated with fluoranthene] results in increased expression of FGF7 mRNA, SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of FGF7 mRNA] CTD PMID:28329830 geldanamycin multiple interactions ISO RGD:69203 6480464 geldanamycin inhibits the reaction [ammonium trichloro(dioxoethylene-O, O'-)tellurate results in increased expression of FGF7 protein] CTD PMID:14656992 geldanamycin multiple interactions ISO RGD:62097 6480464 geldanamycin inhibits the reaction [ammonium trichloro(dioxoethylene-O, O'-)tellurate results in increased expression of FGF7 protein] CTD PMID:14656992 glucose affects transport ISO RGD:62097 6480464 FGF7 protein affects the transport of Glucose CTD PMID:12757114 graphite affects expression EXP 6480464 Graphite affects the expression of FGF7 mRNA CTD PMID:29933104 heparan sulfate affects binding ISO RGD:69203 6480464 Heparitin Sulfate binds to FGF7 protein CTD PMID:15769253 heparin affects binding EXP 6480464 [Heparin binds to FGFR2 protein alternative form] which binds to FGF7 protein CTD PMID:10860838 hyaluronic acid increases chemical synthesis EXP 6480464 FGF7 protein results in increased chemical synthesis of Hyaluronic Acid CTD PMID:14506240 hydrogen peroxide decreases response to substance ISO RGD:69203 6480464 FGF7 protein results in decreased susceptibility to Hydrogen Peroxide CTD PMID:16123449 indometacin multiple interactions EXP 6480464 Indomethacin inhibits the reaction [FGF7 protein results in increased secretion of Dinoprostone] CTD PMID:16169897 lead(0) affects expression ISO RGD:69203 6480464 Lead affects the expression of FGF7 mRNA CTD PMID:28903495 lead(2+) affects expression ISO RGD:69203 6480464 Lead affects the expression of FGF7 mRNA CTD PMID:28903495 lipopolysaccharide decreases response to substance ISO RGD:69203 6480464 FGF7 protein results in decreased susceptibility to Lipopolysaccharides CTD PMID:14962112 lipopolysaccharide decreases expression ISO RGD:62097 6480464 Lipopolysaccharides results in decreased expression of FGF7 mRNA CTD PMID:12057914 lipopolysaccharide increases expression ISO RGD:69203 6480464 Lipopolysaccharides results in increased expression of FGF7 mRNA, Lipopolysaccharides results in increased expression of FGF7 protein CTD PMID:11842940 LY294002 multiple interactions ISO RGD:69203 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[FGF7 protein results in increased phosphorylation of AKT1 protein] which results in increased expression of ESR1 protein] more ... CTD PMID:16162944 , PMID:19661335 medroxyprogesterone acetate decreases expression ISO RGD:69203 6480464 Medroxyprogesterone Acetate results in decreased expression of FGF7 mRNA CTD PMID:20843944 methotrexate increases expression ISO RGD:69203 6480464 Methotrexate results in increased expression of FGF7 mRNA CTD PMID:19192274 N-acetyl-L-cysteine multiple interactions ISO RGD:69203 6480464 Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of and results in increased secretion of FGF7 protein] CTD PMID:26138014 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of FGF7 mRNA CTD PMID:20360939 naphthalene multiple interactions ISO RGD:69203 6480464 [FGF7 protein modified form results in decreased expression of CYP2F2 mRNA] which results in decreased susceptibility to naphthalene CTD PMID:18385170 nickel atom decreases expression ISO RGD:62097 6480464 Nickel results in decreased expression of FGF7 mRNA CTD PMID:18922574 nifedipine increases secretion ISO RGD:69203 6480464 Nifedipine results in increased secretion of FGF7 protein CTD PMID:11023675 nifedipine increases expression ISO RGD:69203 6480464 Nifedipine results in increased expression of FGF7 mRNA CTD PMID:11023675 nitrofen decreases expression EXP 6480464 nitrofen results in decreased expression of FGF7 mRNA CTD PMID:12861530 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of FGF7 mRNA CTD PMID:25729387 paclitaxel multiple interactions ISO RGD:69203 6480464 [Cisplatin co-treated with Paclitaxel] results in increased expression of FGF7 mRNA CTD PMID:20705681 pentanal decreases expression ISO RGD:69203 6480464 pentanal results in decreased expression of FGF7 mRNA CTD PMID:26079696 phenethyl caffeate multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of FGF7 mRNA CTD PMID:20360939 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:62097 6480464 [Methylcholanthrene co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of FGF7 mRNA CTD PMID:23519560 pioglitazone multiple interactions ISO RGD:62097 6480464 [N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of FGF7 mRNA CTD PMID:27935865 prostaglandin E2 increases secretion EXP 6480464 FGF7 protein results in increased secretion of Dinoprostone CTD PMID:16169897 prostaglandin E2 multiple interactions EXP 6480464 Indomethacin inhibits the reaction [FGF7 protein results in increased secretion of Dinoprostone] CTD PMID:16169897 quercetin increases expression ISO RGD:69203 6480464 Quercetin results in increased expression of FGF7 mRNA CTD PMID:15309432 resveratrol decreases expression ISO RGD:62097 6480464 resveratrol results in decreased expression of FGF7 mRNA CTD PMID:23525482 SB 203580 multiple interactions ISO RGD:62097 6480464 SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of FGF7 mRNA] CTD PMID:28329830 shikimic acid increases expression ISO RGD:62097 6480464 Shikimic Acid results in increased expression of FGF7 mRNA CTD PMID:15265014 sirolimus multiple interactions ISO RGD:69203 6480464 Sirolimus inhibits the reaction [TP73 protein results in increased expression of FGF7 mRNA] CTD PMID:21245298 sodium atom increases transport ISO RGD:62097 6480464 FGF7 protein results in increased transport of Sodium CTD PMID:12757114 sodium aurothiomalate increases expression ISO RGD:69203 6480464 Gold Sodium Thiomalate results in increased expression of FGF7 mRNA CTD PMID:19192274 sunitinib decreases expression ISO RGD:69203 6480464 Sunitinib results in decreased expression of FGF7 mRNA CTD PMID:31533062 suramin affects localization ISO RGD:69203 6480464 Suramin affects the localization of FGF7 protein CTD PMID:15733146 suramin multiple interactions ISO RGD:69203 6480464 Suramin inhibits the reaction [FGF7 protein binds to FGFR2 protein] CTD PMID:15733146 tamoxifen decreases response to substance ISO RGD:69203 6480464 FGF7 results in decreased susceptibility to Tamoxifen CTD PMID:18575591 tamoxifen multiple interactions ISO RGD:69203 6480464 FGFR2 inhibits the reaction [FGF7 results in decreased susceptibility to Tamoxifen] CTD PMID:18575591 tetrachloromethane increases expression ISO RGD:62097 6480464 Carbon Tetrachloride results in increased expression of FGF7 mRNA CTD PMID:17484886 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of FGF7 mRNA CTD PMID:17692400 tetraphene increases expression ISO RGD:62097 6480464 benz(a)anthracene results in increased expression of FGF7 mRNA CTD PMID:26377693 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of FGF7 mRNA CTD PMID:23411599 topotecan increases expression EXP 6480464 Topotecan results in increased expression of FGF7 mRNA CTD PMID:25729387 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of FGF7 mRNA CTD PMID:25729387 trichloroethene increases expression ISO RGD:62097 6480464 Trichloroethylene results in increased expression of FGF7 mRNA CTD PMID:15363585 trimellitic anhydride decreases expression ISO RGD:62097 6480464 trimellitic anhydride results in decreased expression of FGF7 mRNA CTD PMID:19042947 valproic acid decreases methylation ISO RGD:69203 6480464 Valproic Acid results in decreased methylation of FGF7 gene CTD PMID:29154799 wortmannin multiple interactions ISO RGD:69203 6480464 wortmannin inhibits the reaction [FGF7 protein results in increased expression of PLAC1 mRNA] CTD PMID:15803460
Biological Process actin cytoskeleton reorganization ISO RGD:69203 1624291 (PMID:17449030) RGD PMID:17449030 actin cytoskeleton reorganization IEA UniProtKB:P21781 , ensembl:ENSP000002678431600115 GO_REF:0000107 Ensembl GO_REF:0000107 branching involved in salivary gland morphogenesis ISO RGD:62097 1624291 (MGI:MGI:3813176, PMID:18559345) RGD MGI:MGI:3813176 , PMID:18559345 branching involved in salivary gland morphogenesis IEA UniProtKB:P36363 , ensembl:ENSMUSP000000696811600115 GO_REF:0000107 Ensembl GO_REF:0000107 fibroblast growth factor receptor signaling pathway ISO RGD:69203 1624291 UniProtKB:P21802 (PMID:8663044) RGD PMID:8663044 fibroblast growth factor receptor signaling pathway IEA UniProtKB:P21781 , ensembl:ENSP000002678431600115 GO_REF:0000107 Ensembl GO_REF:0000107 hair follicle morphogenesis ISO RGD:62097 1624291 (MGI:MGI:1933622, PMID:11098134) RGD MGI:MGI:1933622 , PMID:11098134 hair follicle morphogenesis IEA UniProtKB:P36363 , ensembl:ENSMUSP000000696811600115 GO_REF:0000107 Ensembl GO_REF:0000107 lung development IMP 68696 RGD mesenchymal cell proliferation ISO RGD:69203 1624291 (PMID:11023837) RGD PMID:11023837 mesenchymal cell proliferation IEA UniProtKB:P21781 , ensembl:ENSP000002678431600115 GO_REF:0000107 Ensembl GO_REF:0000107 ovarian follicle development IMP 2289108 primordial to primary follicle transition RGD phosphatidylcholine biosynthetic process IMP 68696 surfactant disaturated phosphatidylcholine (DSPC) synthesis RGD phospholipid biosynthetic process IMP 68696 RGD positive chemotaxis ISO RGD:69203 1624291 (PMID:17449030) RGD PMID:17449030 positive chemotaxis IEA UniProtKB:P21781 , ensembl:ENSP000002678431600115 GO_REF:0000107 Ensembl GO_REF:0000107 positive regulation of cell division IEA UniProtKB-KW:KW-0497 1600115 GO_REF:0000037 UniProt GO_REF:0000037 positive regulation of cell population proliferation ISO RGD:69203 1624291 UniProtKB:P21802 (PMID:8663044) RGD PMID:8663044 positive regulation of cell population proliferation ISO RGD:62097 1624291 MGI:MGI:1096350 (MGI:MGI:2686859 more ... RGD MGI:MGI:2686859 more ... positive regulation of epithelial cell proliferation IMP 2289254 mesothelial cells RGD positive regulation of epithelial cell proliferation IDA 2289860 Dunning R3327PAP prostate tumor epithelial cells RGD positive regulation of epithelial cell proliferation ISO RGD:69203 1624291 (PMID:11493558), (PMID:15690149) RGD PMID:11493558 , PMID:15690149 positive regulation of epithelial cell proliferation ISO RGD:62097 1624291 (MGI:MGI:3701403, PMID:17187775) RGD MGI:MGI:3701403 , PMID:17187775 positive regulation of epithelial cell proliferation involved in lung morphogenesis ISO RGD:69203 1624291 (PMID:9740653) RGD PMID:9740653 positive regulation of epithelial cell proliferation involved in lung morphogenesis IEA UniProtKB:P21781 , ensembl:ENSP000002678431600115 GO_REF:0000107 Ensembl GO_REF:0000107 positive regulation of keratinocyte migration ISO RGD:69203 1624291 (PMID:17449030) RGD PMID:17449030 positive regulation of keratinocyte migration IEA UniProtKB:P21781 , ensembl:ENSP000002678431600115 GO_REF:0000107 Ensembl GO_REF:0000107 positive regulation of keratinocyte proliferation ISO RGD:69203 1624291 (PMID:17449030) RGD PMID:17449030 positive regulation of keratinocyte proliferation IEA UniProtKB:P21781 , ensembl:ENSP000002678431600115 GO_REF:0000107 Ensembl GO_REF:0000107 positive regulation of peptidyl-tyrosine phosphorylation ISO RGD:69203 1624291 (PMID:17449030) RGD PMID:17449030 positive regulation of peptidyl-tyrosine phosphorylation IEA UniProtKB:P21781 , ensembl:ENSP000002678431600115 GO_REF:0000107 Ensembl GO_REF:0000107 positive regulation of transcription, DNA-templated ISO RGD:62097 1624291 (MGI:MGI:3708201, PMID:17394208) RGD MGI:MGI:3708201 , PMID:17394208 positive regulation of transcription, DNA-templated IEA UniProtKB:P36363 , ensembl:ENSMUSP000000696811600115 GO_REF:0000107 Ensembl GO_REF:0000107 protein localization to cell surface ISO RGD:69203 1624291 (PMID:17449030) RGD PMID:17449030 protein localization to cell surface IEA UniProtKB:P21781 , ensembl:ENSP000002678431600115 GO_REF:0000107 Ensembl GO_REF:0000107 regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling ISO RGD:62097 1624291 (MGI:MGI:3813176, PMID:18559345) RGD MGI:MGI:3813176 , PMID:18559345 regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling IEA UniProtKB:P36363 , ensembl:ENSMUSP000000696811600115 GO_REF:0000107 Ensembl GO_REF:0000107 secretion by lung epithelial cell involved in lung growth ISO RGD:69203 1624291 (PMID:10541313) RGD PMID:10541313 secretion by lung epithelial cell involved in lung growth IEA UniProtKB:P21781 , ensembl:ENSP000002678431600115 GO_REF:0000107 Ensembl GO_REF:0000107 surfactant homeostasis IMP 68696 RGD wound healing IDA 2289087 RGD Cellular Component extracellular region ISO RGD:62097 1624291 (MGI:MGI:2668753, PMID:12837279) RGD MGI:MGI:2668753 , PMID:12837279 extracellular region IEA UniProtKB:P36363 , ensembl:ENSMUSP000000696811600115 GO_REF:0000107 Ensembl GO_REF:0000107 extracellular space IDA 2289254 RGD Golgi apparatus ISO RGD:62097 1624291 (MGI:MGI:2668753, PMID:12837279) RGD MGI:MGI:2668753 , PMID:12837279 Golgi apparatus IEA UniProtKB:P36363 , ensembl:ENSMUSP000000696811600115 GO_REF:0000107 Ensembl GO_REF:0000107 Molecular Function chemoattractant activity ISO RGD:69203 1624291 (PMID:17449030) RGD PMID:17449030 chemoattractant activity IEA UniProtKB:P21781 , ensembl:ENSP000002678431600115 GO_REF:0000107 Ensembl GO_REF:0000107 fibroblast growth factor receptor binding IEA InterPro:IPR028247 1600115 GO_REF:0000002 InterPro GO_REF:0000002 growth factor activity IMP 2289254 RGD growth factor activity IEA UniProtKB-KW:KW-0339 1600115 GO_REF:0000038 UniProt GO_REF:0000038 heparin binding IDA 2289271 RGD protein binding ISO RGD:62097 1624291 UniProtKB:O70514 (MGI:MGI:3589509 , PMID:15806171) RGD MGI:MGI:3589509 , PMID:15806171 protein binding ISO RGD:69203 1624291 UniProtKB:P21802-3 (PMID:1309608) RGD PMID:1309608 type 2 fibroblast growth factor receptor binding IDA 2289271 FGFR2IIIb isoform only RGD
Gene-Chemical Interaction Annotations
